• This topic has 1 voice and 0 replies.
Viewing 0 reply threads
  • Author
    Posts
    • #13112
      Forum Moderator
      Keymaster

      Xadago (safinamide) has been approved in Australia as an add-on therapy to a levodopa/carbidopa regimen for adults with idiopathic Parkinson’s disease. Click here to learn more.

      What are your thoughts on this news?

Viewing 0 reply threads
  • You must be logged in to reply to this topic.

©2021 KLEO Template a premium and multipurpose theme from Seventh Queen

CONTACT US

We're not around right now. But you can send us an email and we'll get back to you, asap.

Sending

Log in with your credentials

or    

Forgot your details?

Create Account